Bestafter OÜ
Bestafter OÜ is a OÜ based in Tallinn, registry code 14962240, status: active. Main activity: Manufacture of basic pharmaceutical products. According to EMTA, turnover for Q3 2026 was €0 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2025 100 €above 15% of companiesindustry median 48 003 € · companies in the industry: 19
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | — | — | — | — |
| Q1 2026 | 100 | 24 | — | — |
| Q4 2025 | — | — | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | — | — | — | — |
| Q1 2025 | — | — | — | — |
| Q4 2024 | 100 | 22 | — | — |
| Q3 2024 | — | — | — | — |
| Q2 2024 | 100 | 22 | — | — |
| Q1 2024 | 125 | 25 | — | — |
| Q4 2023 | 100 | 20 | — | — |
| Q3 2023 | — | — | — | — |
| Q2 2023 | 100 | 20 | — | — |
| Q1 2023 | 100 | 20 | — | — |
| Q4 2022 | — | — | — | — |
| Q3 2022 | 200 | 40 | — | — |
| Q2 2022 | 100 | 20 | — | — |
| Q1 2022 | — | — | — | — |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 100 | 47 | 0 | 112 398 | 778 | 0 |
| 2024 | 200 | 37 | 0 | 114 851 | 3 231 | 0 |
| 2023 | 325 | -4 | 0 | 114 738 | 3 194 | 0 |
| 2022 | 400 | -74 | 0 | 114 437 | 3 198 | 0 |
| 2021 | 780 | 772 | 0 | 113 972 | 3 272 | 0 |
| 2020 | 0 | 1 | 0 | 113 000 | 2 501 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 25 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 12 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 24 Apr 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 13 Jul 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 28 Jul 2022 | Company’s own | e-Äriregister |
| 2020 | 4 May 2020 – 31 Dec 2020 | 29 Mar 2022 | Company’s own | e-Äriregister |
Board
- Imre RammulBoard member · since 4 May 2020
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Imre RammulNatural person · 2 500 €
Beneficial owners
- Imre RammulMember of a senior management body (management or supervisory board) · since 4 May 2020
- Kristi PiiperMember of a senior management body (management or supervisory board) · since 4 May 2020
Founders and other persons
- Imre RammulFounder · 1 250 € · 30 Apr 2020
- Kristi PiiperFounder · 1 250 € · 30 Apr 2020
Related companies
Activities (EMTAK)
- 21101Manufacture of basic pharmaceutical products Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50145282 / 5 6 Feb 2026 |
Amendment entry | In force 6 Feb 2026 |
||
| Ä 50145282 / M3 5 Feb 2026 |
Ruling to eliminate deficiencies | 20 Feb 2026 | Deficiencies eliminated 6 Feb 2026 |
|
| Ä 50145282 / 4 5 Feb 2026 |
Amendment entry | In force 5 Feb 2026 |
||
| Ä 50145282 / M2 4 Feb 2026 |
Ruling to eliminate deficiencies | 19 Feb 2026 | Deficiencies eliminated 5 Feb 2026 |
|
| Ä 50145282 / 3 27 Nov 2024 |
Amendment entry | In force 27 Nov 2024 |
||
| Ä 50145282 / 2 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50145282 / M1 8 Mar 2022 |
Warning of a fine: annual report not filed | 7 Apr 2022 | Deficiencies eliminated 29 Mar 2022 |
|
| Ä 50145282 4 May 2020 |
First entry | In force 4 May 2020 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data